Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
clinical trials
deals
indiana blog main
indiana top stories
life sciences
national blog main
national top stories
rna interference
2
×
san francisco blog main
san francisco top stories
2
×
wisconsin blog main
wisconsin top stories
alexion pharmaceuticals
alnylam pharmaceutials
alnylam pharmaceuticals
ambys medicines
amicus therapeutics
ampio pharmaceuticals
angelman syndrome
arrowhead pharmaceuticals
athenex
biomarin pharmaceutical
biotech
bluebird bio
boehringer ingelheim
boston
boulder/denver blog main
boulder/denver top stories
centers for medicare & medicaid services
chris collins
competitive generic therapy
cystic fibrosis
detroit blog main
detroit top stories
dicerna pharmaceuticals
eli lilly
fda
gene therapy
What
long
2
×
abandoning
ago
aren’t
baggage
bio
companies
cuts
deal
developers
development
dicerna
drug
drugs
fda
free
gene
gets
help
imminent
interference
medicare
medicines
moves
news
noteworthy
patients
pharma
prices
rna
rnai
road
roundup
rulings
separate
signs
small
therapy
they’ll
wasn’t
Language
Current search:
long
×
" san francisco top stories "
×
" rna interference "
×
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More
